Tomoko Ito

Tokyo, 1138657, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Structural basis for transcriptional coactivator recognition by SMAD2 in TGF-β signaling.

Structural basis for transcriptional coactivator recognition by SMAD2 in TGF-β signaling.

Journal: Science signaling

Published: December 16, 2020

Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells.

Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells.

Journal: Pharmaceutics

Published: November 25, 2020

Structural basis for receptor-regulated SMAD recognition by MAN1.

Structural basis for receptor-regulated SMAD recognition by MAN1.

Journal: Nucleic acids research

Published: April 27, 2018

Hydrophobic patches on SMAD2 and SMAD3 determine selective binding to cofactors.

Hydrophobic patches on SMAD2 and SMAD3 determine selective binding to cofactors.

Journal: Science signaling

Published: March 29, 2018

Innate immunity mediated by dendritic cells/macrophages plays a central role in the early period in tumor treatment using gene of Mycobacterium tuberculosis antigen.

Innate immunity mediated by dendritic cells/macrophages plays a central role in the early period in tumor treatment using gene of Mycobacterium tuberculosis antigen.

Journal: The Journal of veterinary medical science

Published: January 10, 2018

Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy.

Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy.

Journal: Biotechnology letters

Published: March 07, 2016

Highly Effective Non-Viral Antitumor Gene Therapy System Comprised of Biocompatible Small Plasmid Complex Particles Consisting of pDNA, Anionic Polysaccharide, and Fully Deprotected Linear Polyethylenimine.

Highly Effective Non-Viral Antitumor Gene Therapy System Comprised of Biocompatible Small Plasmid Complex Particles Consisting of pDNA, Anionic Polysaccharide, and Fully Deprotected Linear Polyethylenimine.

Journal: Pharmaceutics

Published: May 31, 2015

Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a "Danger Signal" to Block Immune Escape of Tumor Cells.

Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a "Danger Signal" to Block Immune Escape of Tumor Cells.

Journal: Pharmaceutics

Published: May 31, 2015

Application of calcium phosphate as a controlled-release device.

Application of calcium phosphate as a controlled-release device.

Journal: Biological & pharmaceutical bulletin

Published: November 06, 2013

Preparation of calcium phosphate nanocapsule including deoxyribonucleic acid-polyethyleneimine-hyaluronic acid ternary complex for durable gene delivery.

Preparation of calcium phosphate nanocapsule including deoxyribonucleic acid-polyethyleneimine-hyaluronic acid ternary complex for durable gene delivery.

Journal: Journal of pharmaceutical sciences

Published: May 27, 2013

Controlled release of simvastatin from biomimetic β-TCP drug delivery system.

Controlled release of simvastatin from biomimetic β-TCP drug delivery system.

Journal: PloS one

Published: October 20, 2012

Simvastatin-loaded β-TCP drug delivery system induces bone formation and prevents rhabdomyolysis in OVX mice.

Simvastatin-loaded β-TCP drug delivery system induces bone formation and prevents rhabdomyolysis in OVX mice.

Journal: Advanced healthcare materials

Published: September 25, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026